Day CP - Search Results

1

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.

Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP. Donaldson PT, et al. Among authors: day cp. J Hepatol. 2010 Dec;53(6):1049-53. doi: 10.1016/j.jhep.2010.05.033. Epub 2010 Aug 1. J Hepatol. 2010. PMID: 20800921

2

No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis.

Bashir R, Day CP, James OF, Ogilvie DJ, Sykes B, Bassendine MF. Bashir R, et al. Among authors: day cp. J Hepatol. 1992 Nov;16(3):316-9. doi: 10.1016/s0168-8278(05)80662-2. J Hepatol. 1992. PMID: 1362577

3

Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage.

Day CP, Bashir R, James OF, Bassendine MF, Crabb DW, Thomasson HR, Li TK, Edenberg HJ. Day CP, et al. Hepatology. 1991 Nov;14(5):798-801. doi: 10.1002/hep.1840140509. Hepatology. 1991. PMID: 1937384

4

Digoxin-like factors in liver disease.

Day CP, James OF. Day CP, et al. J Hepatol. 1989 Sep;9(2):281-4. doi: 10.1016/0168-8278(89)90064-0. J Hepatol. 1989. PMID: 2681397 Review. No abstract available.

5

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: day cp. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

6

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

Grove J, Daly AK, Bassendine MF, Day CP. Grove J, et al. Among authors: day cp. Hepatology. 1997 Jul;26(1):143-6. doi: 10.1002/hep.510260119. Hepatology. 1997. PMID: 9214463

7

Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.

Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Day CP, et al. Diabetologia. 1998 Apr;41(4):430-4. doi: 10.1007/s001250050926. Diabetologia. 1998. PMID: 9562347

8

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Smith BC, et al. Among authors: day cp. Hepatology. 1998 Jun;27(6):1695-9. doi: 10.1002/hep.510270631. Hepatology. 1998. PMID: 9620344

9

No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.

Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, Jones DE. Zappala F, et al. Among authors: day cp. J Hepatol. 1998 May;28(5):820-3. doi: 10.1016/s0168-8278(98)80232-8. J Hepatol. 1998. PMID: 9625317

10

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.

Grove J, Brown AS, Daly AK, Bassendine MF, James OF, Day CP. Grove J, et al. Among authors: day cp. Pharmacogenetics. 1998 Aug;8(4):335-42. doi: 10.1097/00008571-199808000-00007. Pharmacogenetics. 1998. PMID: 9731720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters